Laboratorios Richmond S.A.C.I.F.'s latest marketcap:
As of 07/04/2025, Laboratorios Richmond S.A.C.I.F.'s market capitalization has reached $88.84 M. According to our data, Laboratorios Richmond S.A.C.I.F. is the 25507th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 88.84 M |
| Revenue (ttm) | 77.7 M |
| Net Income (ttm) | 15.14 M |
| Shares Out | 80.75 M |
| EPS (ttm) | 0.19 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 05/14/2025 |
| Earnings Date | 08/08/2025 |
Laboratorios Richmond S.A.C.I.F.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/04/2025 | ARS 88.84 M | -23.96% | 25507 |
| 12/30/2024 | ARS 144.95 B | 156.98% | 21139 |
| 12/29/2023 | ARS 56.4 B | 79.56% | 25483 |
| 12/30/2022 | ARS 31.41 B | 75.23% | 19262 |
| 12/30/2021 | ARS 17.93 B | 92.21% | 19968 |
| 12/30/2020 | ARS 9.33 B | -0.43% | 20260 |
| 12/30/2019 | ARS 9.37 B | 219.56% | 16040 |
| 12/28/2018 | ARS 2.93 B | 39.76% | 18691 |
| 12/29/2017 | ARS 2.1 B | 17407 |
Company Profile
About Laboratorios Richmond S.A.C.I.F.
Laboratorios Richmond S.A.C.I.F. is a pharmaceutical company specializing in the development and manufacturing of a diverse range of medical products. Established in 1935 and headquartered in Buenos Aires, Argentina, the company serves markets across Latin America, Africa, Asia, and the Middle East.
Key Product Offerings
- Antiretroviral Products: Treatments for human immunodeficiency virus (HIV).
- Oncology & Oncohematology Drugs: Medications targeting cancer and blood-related disorders.
- Cardiometabolic Drugs: Includes antihypertensives, hypocholesterolemics, platelet antiaggregants, and hypoglycemic medications.
- Neurological & Psychiatric Drugs: Covers analgesics, antipsychotics, antidepressants, anti-dementia drugs, antiepileptics, hypnotics, and treatments for multiple sclerosis.
With decades of expertise, Laboratorios Richmond S.A.C.I.F. remains a trusted name in the global pharmaceutical industry.
Frequently Asked Questions
-
What is Laboratorios Richmond S.A.C.I.F.'s (BCBA-RICH) current market cap?As of 07/04/2025, Laboratorios Richmond S.A.C.I.F. (including the parent company, if applicable) has an estimated market capitalization of $88.84 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Laboratorios Richmond S.A.C.I.F. (BCBA-RICH) rank globally by market cap?Laboratorios Richmond S.A.C.I.F. global market capitalization ranking is approximately 25507 as of 07/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.